These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27498404)

  • 1. Expanding the view of breast cancer metabolism: Promising molecular targets and therapeutic opportunities.
    Harrelson JP; Lee MW
    Pharmacol Ther; 2016 Nov; 167():60-73. PubMed ID: 27498404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
    Geisler J; Sasano H; Chen S; Purohit A
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors.
    Bacci M; Giannoni E; Fearns A; Ribas R; Gao Q; Taddei ML; Pintus G; Dowsett M; Isacke CM; Martin LA; Chiarugi P; Morandi A
    Cancer Res; 2016 Mar; 76(6):1615-26. PubMed ID: 26795347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen producing enzymes and mammary carcinogenesis: a review.
    Subramanian A; Salhab M; Mokbel K
    Breast Cancer Res Treat; 2008 Sep; 111(2):191-202. PubMed ID: 17934808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.
    Chanplakorn N; Chanplakorn P; Suzuki T; Ono K; Chan MS; Miki Y; Saji S; Ueno T; Toi M; Sasano H
    Breast Cancer Res Treat; 2010 Apr; 120(3):639-48. PubMed ID: 20151319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    Ahmad I; Shagufta
    Eur J Med Chem; 2015 Sep; 102():375-86. PubMed ID: 26301554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mitochondrial function for the treatment of breast cancer.
    Deus CM; Coelho AR; Serafim TL; Oliveira PJ
    Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer treatment and sulfotransferase.
    Ji XW; Zhou TY; Lu Y; Wei MJ; Lu W; Cho WC
    Expert Opin Ther Targets; 2015 Jun; 19(6):821-34. PubMed ID: 25677121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
    Li L; Eid JE; Paz AC; Trent JC
    BioDrugs; 2017 Oct; 31(5):379-392. PubMed ID: 28840584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid sulfatase inhibitors: promising new therapy for breast cancer.
    Sadozai H
    J Pak Med Assoc; 2013 Apr; 63(4):509-15. PubMed ID: 23905452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipokines as therapeutic targets in breast cancer treatment.
    Cha YJ; Koo JS
    Expert Opin Ther Targets; 2018 Nov; 22(11):941-953. PubMed ID: 30332900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective estrogen enzyme modulators in breast cancer: a review.
    Pasqualini JR
    Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment.
    Gu G; Dustin D; Fuqua SA
    Curr Opin Pharmacol; 2016 Dec; 31():97-103. PubMed ID: 27883943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer.
    Islam RA; Hossain S; Chowdhury EH
    Curr Cancer Drug Targets; 2017; 17(8):707-721. PubMed ID: 28359244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC; Okubo T; Sun XZ; Chen S
    Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors and breast cancer.
    Miller WR
    Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.